Methods of treating measles infectious disease in mammals
The invention provides for a measles vaccine utilizing a human codon-optimized polynucleotide encoding a measles virus polypeptide, such as HA or F protein. Optionally, the vaccine is administered with an adjuvant and is especially useful for immunizing an infant mammal.
VILALTA ADRIAN [US]; JIMENEZ GRETCHEN [US]; GRIFFIN DIANE E [US]
Type of Offer:
« More Biotech Patents